File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Primary squamous cell carcinoma of the breast in two Chinese women

TitlePrimary squamous cell carcinoma of the breast in two Chinese women
Authors
KeywordsRadiotherapy
Cisplatin
Carcinoma, squamous cell
Breast neoplasms
Doxorubicin
Issue Date2012
Citation
Hong Kong Journal of Radiology, 2012, v. 15, n. 4, p. 256-259 How to Cite?
AbstractPrimary squamous cell carcinoma of the breast is a rare breast neoplasm. This report describes two Chinese women diagnosed with primary squamous cell carcinoma of the breast. The first patient was a 54-year-old woman with stage pT1cN0M0 triple-negative disease treated with wide local excision and axillary dissection followed by adjuvant chemotherapy with adriamycin and cyclophosphamide, and adjuvant radiotherapy. She was disease-free on follow-up at 19 months. The second patient was a 63-year-old woman presenting with a 10-cm right breast mass. She was given one cycle of neoadjuvant chemotherapy using docetaxel, cisplatin, and 5-fluorouracil without clinical response. Modified radical mastectomy with transverse rectus abdominis myocutaneous flap was performed. Pathology showed stage pT3N0M0 triple-negative disease. Adjuvant locoregional radiotherapy was given. She was disease-free on follow-up at 19 months. As reported in the literature, squamous cell carcinoma of the breast is mostly triple negative, of large size, and has infrequent nodal involvement at presentation. The disease runs a more aggressive clinical course. There is no consensus on the role and mode of adjuvant treatment. The choice of chemotherapy regimen for this histology remains to be defined. © 2012 Hong Kong College of Radiologists.
Persistent Identifierhttp://hdl.handle.net/10722/251621
ISSN
2023 Impact Factor: 0.2
2023 SCImago Journal Rankings: 0.127

 

DC FieldValueLanguage
dc.contributor.authorChan, T. W.-
dc.contributor.authorLeung, A. K.C.-
dc.contributor.authorNgan, K. C.-
dc.date.accessioned2018-03-08T05:00:30Z-
dc.date.available2018-03-08T05:00:30Z-
dc.date.issued2012-
dc.identifier.citationHong Kong Journal of Radiology, 2012, v. 15, n. 4, p. 256-259-
dc.identifier.issn2223-6619-
dc.identifier.urihttp://hdl.handle.net/10722/251621-
dc.description.abstractPrimary squamous cell carcinoma of the breast is a rare breast neoplasm. This report describes two Chinese women diagnosed with primary squamous cell carcinoma of the breast. The first patient was a 54-year-old woman with stage pT1cN0M0 triple-negative disease treated with wide local excision and axillary dissection followed by adjuvant chemotherapy with adriamycin and cyclophosphamide, and adjuvant radiotherapy. She was disease-free on follow-up at 19 months. The second patient was a 63-year-old woman presenting with a 10-cm right breast mass. She was given one cycle of neoadjuvant chemotherapy using docetaxel, cisplatin, and 5-fluorouracil without clinical response. Modified radical mastectomy with transverse rectus abdominis myocutaneous flap was performed. Pathology showed stage pT3N0M0 triple-negative disease. Adjuvant locoregional radiotherapy was given. She was disease-free on follow-up at 19 months. As reported in the literature, squamous cell carcinoma of the breast is mostly triple negative, of large size, and has infrequent nodal involvement at presentation. The disease runs a more aggressive clinical course. There is no consensus on the role and mode of adjuvant treatment. The choice of chemotherapy regimen for this histology remains to be defined. © 2012 Hong Kong College of Radiologists.-
dc.languageeng-
dc.relation.ispartofHong Kong Journal of Radiology-
dc.subjectRadiotherapy-
dc.subjectCisplatin-
dc.subjectCarcinoma, squamous cell-
dc.subjectBreast neoplasms-
dc.subjectDoxorubicin-
dc.titlePrimary squamous cell carcinoma of the breast in two Chinese women-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.scopuseid_2-s2.0-84872738693-
dc.identifier.volume15-
dc.identifier.issue4-
dc.identifier.spage256-
dc.identifier.epage259-
dc.identifier.issnl2223-6619-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats